Raymond James Financial Inc. purchased a new position in shares of TriMas Co. (NASDAQ:TRS – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 272,381 shares of the industrial products company’s stock, valued at approximately $6,698,000. Raymond James Financial Inc. owned about 0.67% of TriMas at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. Intech Investment Management LLC bought a new stake in TriMas during the 3rd quarter worth approximately $269,000. Paloma Partners Management Co bought a new stake in TriMas during the 3rd quarter worth approximately $293,000. XTX Topco Ltd bought a new stake in TriMas during the 3rd quarter worth approximately $371,000. JPMorgan Chase & Co. grew its position in TriMas by 3.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock worth $982,000 after acquiring an additional 1,227 shares during the last quarter. Finally, FMR LLC grew its position in TriMas by 1.7% during the 3rd quarter. FMR LLC now owns 44,082 shares of the industrial products company’s stock worth $1,125,000 after acquiring an additional 729 shares during the last quarter. 99.42% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Separately, BWS Financial reiterated a “buy” rating and issued a $40.00 price objective on shares of TriMas in a research report on Friday, February 28th.
Insider Buying and Selling at TriMas
In other news, CFO Scott A. Mell sold 2,218 shares of the firm’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $22.54, for a total value of $49,993.72. Following the transaction, the chief financial officer now directly owns 26,288 shares in the company, valued at $592,531.52. This trade represents a 7.78 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Shawn Sedaghat purchased 554,149 shares of TriMas stock in a transaction dated Monday, March 10th. The stock was bought at an average price of $24.07 per share, for a total transaction of $13,338,366.43. Following the completion of the transaction, the director now directly owns 900,974 shares in the company, valued at $21,686,444.18. The trade was a 159.78 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 806,246 shares of company stock worth $19,338,213. Insiders own 1.10% of the company’s stock.
TriMas Stock Down 3.0 %
Shares of TRS opened at $24.25 on Monday. The firm has a market capitalization of $984.14 million, a price-to-earnings ratio of 37.89 and a beta of 0.65. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The business’s fifty day moving average price is $23.77 and its two-hundred day moving average price is $25.04. TriMas Co. has a 52 week low of $19.33 and a 52 week high of $28.51.
TriMas Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 28th were given a $0.04 dividend. The ex-dividend date was Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a yield of 0.66%. TriMas’s payout ratio is 27.12%.
TriMas Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Read More
- Five stocks we like better than TriMas
- What to Know About Investing in Penny Stocks
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Growth Stocks: What They Are, Examples and How to Invest
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS – Free Report).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.